Analysts’ Updated EPS Estimates for December 17th (ASML, COUR, EEX, FTNT, GWRE, HSBC, HUT, NFLX, NJR, PANW)

Analysts’ updated eps estimates for Wednesday, December 17th:

ASML (NASDAQ:ASML) had its neutral rating reiterated by analysts at Barclays PLC.

Coursera (NYSE:COUR) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $12.00 price target on the stock.

Emerald (NYSE:EEX) had its buy rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $7.70 price target on the stock.

Fortinet (NASDAQ:FTNT) had its underweight rating reissued by analysts at JPMorgan Chase & Co.. They currently have a $75.00 target price on the stock, down from their previous target price of $85.00.

Guidewire Software (NYSE:GWRE) was upgraded by analysts at DA Davidson from a neutral rating to a buy rating. The firm currently has $250.00 price target on the stock, up from their previous price target of $246.00.

Guidewire Software (NYSE:GWRE) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $250.00 target price on the stock.

HSBC (NYSE:HSBC) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating.

Hut 8 (NASDAQ:HUT) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $55.00 price target on the stock.

Netflix (NASDAQ:NFLX) had its buy rating reiterated by analysts at Jefferies Financial Group Inc..

NewJersey Resources (NYSE:NJR) was upgraded by analysts at Mizuho from a neutral rating to an outperform rating. The firm currently has $54.00 price target on the stock, up from their previous price target of $51.00.

Palo Alto Networks (NASDAQ:PANW) had its overweight rating reissued by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a $235.00 target price on the stock.

Procore Technologies (NYSE:PCOR) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $88.00 target price on the stock.

Recursion Pharmaceuticals (NASDAQ:RXRX) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. The firm currently has $11.00 price target on the stock, up from their previous price target of $10.00.

Summit Therapeutics (NASDAQ:SMMT) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating. Barclays PLC currently has $18.00 price target on the stock, up from their previous price target of $16.00.

Smith & Nephew (LON:SN) was downgraded by analysts at Royal Bank Of Canada to a sector perform rating. They currently have GBX 1,350 price target on the stock, down from their previous price target of GBX 1,700.

Vital Farms (NASDAQ:VITL) had its outperform rating reiterated by analysts at Telsey Advisory Group. They currently have a $50.00 price target on the stock.

VistaGen Therapeutics (NASDAQ:VTGN) was downgraded by analysts at William Blair from an outperform rating to a market perform rating.

VistaGen Therapeutics (NASDAQ:VTGN) was downgraded by analysts at Stifel Nicolaus from a buy rating to a hold rating. They currently have $1.00 target price on the stock.

VistaGen Therapeutics (NASDAQ:VTGN) was downgraded by analysts at Maxim Group from a buy rating to a hold rating.

Xiaomi (OTCMKTS:XIACF) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating.